Below are current clinical trials.14 studies in Kidney Transplant Program
(open studies only).
Filter this list of studies by location, status and more.
Purpose of the study is to implement a culturally-targeted Hispanic transplant program and determine the impact of culturally tailored transplant education and care on living donation in the Hispanic population.
The purpose of this study is to determine the change in exercise capacity by comparing VO2 max results pre & post renal transplant.
The purpose of this study is to see if certain pre-transplant markers are able to predict how the kidney will respond after a liver transplant.
The purpose of this pilot study is to investigate whether contrast-enhanced ultrasound (CEUS) may help evaluate segmental differences in renal perfusion better than doppler ultrasound and thus help direct a biopsy to the most abnormal part of the renal cortex.
The aim of this study is to determine the validity of two tests on bone marrow of sensitized kidney transplant recipients in order to better understand why these patients with antibodies against their donors are at a greater risk of rejection of their transplanted organs.
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against standard lung transplantation.
The purpose of this study is to use renal and kidney plus pancreas transplant patient samples to validate both the clinical utility of the CMV scoring algorithm and develop a clinically useful scoring guide for the BK virus immune competence assay.
The aim of this study is to assess the quality of life among a sample of obese liver transplant recipients and compare it between those who underwent sleeve gastrectomy and those who did not.
This study will collect and store samples of tissue and blood for current and future research studies on Liver and Biliary Tumors.
The purpose of this study of obinutuzumab administered as intravenous (IV) infusion in adults with end stage renal disease is to assess the safety and tolerability of the regimen at week 24 of the desensitization phase and at week 28 post kidney transplantation. All participants will be monitored for a minimum of 12 months following the last obinutuzumab infusion.
June 17, 2017
- Scientific Registry of Transplant Recipients. http://www.srtr.org/default.aspx. Accessed April 7, 2016.
- U.S. News & World Report. U.S. News Best Hospitals 2015-16. http://health.usnews.com/best-hospitals/rankings. Accessed Feb. 22, 2016.
- Orandi BJ, et al. Kidney transplants from incompatible live donors. New England Journal of Medicine. 2016;374:940.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 5, 2016.
- Schinstock CA (expert opinion). Mayo Clinic, Rochester, Minn. April 18, 2014.
- Lallas CD, et al. The development of a laparoscopic donor nephrectomy program in a de novo renal transplant program: Evolution of technique and results in over 200 cases. Journal of the Society of Laparoendoscopic Surgeons. 2006;10:135.
- Mai ML (expert opinion). Mayo Clinic, Jacksonville, Fla. April 26, 2016.
- Stulak JM, et al. Combined heart and abdominal organ transplantation: Excellent outcomes gained from a unique experience. Journal of Heart and Lung Transplantation. 2014;33:S278.
- Li H, et al. Assessing the efficacy of kidney paired donation — Performance of an integrated three-site program. Transplantation. 2014;98:300.
- Cornell LD, et al. Positive crossmatch kidney transplant recipients treated with eculizumab: Outcomes beyond 1 year. American Journal of Transplantation. 2015;15:1293.
- Shapiro R, et al. Benefits and complications of laparoscopic donor nephrectomy. http://www.uptodate.com/home. Accessed March 11, 2016.
- Polycystic kidney disease. National Institutes of Diabetes and Digestive Kidney Diseases. http://kidney.niddk.nih.gov/kudiseases/pubs/polycystic/. Accessed March 16, 2016.
- Raichlin E, et al. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplantation Proceedings. 2011;43:1871.
- Heilman RL, et al. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Transplantation Proceedings. 2005;37:1785.
- Jay CL, et al. Reassessing preemptive kidney transplantation in the United States: Are we making progress? Transplantation. 20165;100:1120. http://www.transplantjournal.com. Accessed April 6, 2016.
- Bentall A, et al. Five-year outcomes in living donor kidney transplants with a positive crossmatch. American Journal of Transplantation. 2013;13:76.
- Prieto M (expert opinion). Mayo Clinic, Rochester, Minn. May 11, 2016.
- Dharnidharka VR, et al. Kidney transplantation in children. New England Journal of Medicine. 2014;371:549.
- Barbara Woodward Lips Patient Education Center. Your child's kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2016.
- Kidney transplant team describes current work. Mayovox. 1967;18:24.
- Kudva YC (expert opinion). Mayo Clinic, Rochester, Minn. March 14, 2016.
- Barbara Woodward Lips Patient Education Center. Kidney transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
- Rossi AP, et al. Evaluation of the potential renal transplant recipient. http://www.uptodate.com/home. Accessed April 6, 2016.
- Cramer CH II (expert opinion). Mayo Clinic, Rochester, Minn. April 27, 2016.
- Li H, et al. The limits of paired donation — Who doesn't get transplanted? American Journal of Transplantation. 2013;13(suppl 5). http://www.atcmeetingsabstracts.com/abstract/limits-of-paired-donation-who-doesn’t-get-transplanted-the/. Accessed April 27, 2016.
- Crespo HS, et al. Kidney transplantation in the septuagenarian. American Journal of Transplantation. 2015;15(suppl 3). http://www.atcmeetingabstracts.com/abstract/kidney-transplantation-in-the-septuagenarian/. Accessed April 27, 2016.
- Taner T, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney International. 2016:89:909.
Kidney Transplant Program